Skip to main content

vociprotafib

Generic: Vociprotafib

vociprotafib: 2 clinical trials tracked.

vociprotafib evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about vociprotafib, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 2 study sponsors

Related indications

Non-Small Cell Lung Cancer
Clinical Trial Registry Records (2)

A Phase 2, Open-Label, Multicenter Study of the Combination of RMC-4630 and Sotorasib for Non-Small Cell Lung Cancer Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

NCT05054725Registry updated 2026-01-06·Phase 2·RVMD
Completed

Primary endpoint: Objective Response Rate (ORR) as Assessed Per RECIST v1.1

Interventionalopen47 enrolledStarted 2021-12Completion 2024-0850 sites · Australia, Canada, France, Germany…Revolution Medicines, Inc.

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Dose Expansion Study of SAR442720 in Combination With Other Agents in Participants With Advanced Malignancies

NCT04418661Registry updated 2025-05-29·Phase 1/Phase 2·SNY
Terminated

Primary endpoint: Part 1: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Treatment-Emergent Serious Adverse Events (TESAEs)

Interventionalopen65 targetStarted 2020-06Completion 2024-0420 sites · Argentina, Australia, Chile, South Korea…Sanofi